• <object id="wyj0v"></object>

    1. <pre id="wyj0v"></pre>
      1. <table id="wyj0v"></table>
        <samp id="wyj0v"><del id="wyj0v"><xmp id="wyj0v"></xmp></del></samp>

        Chorionic Gonadotrophin for injection

        Short Description:


        1. Diagnosis and treatment of prepubertal cryptorchidism.

        2. Male infertility caused by hypopituitarism can be combined with urogonadotropin. Long-term hypogonadotropin function. It should also be supplemented with testosterone therapy.

        3. Anovulatory infertility in women caused by pituitary gonadotropin insufficiency is often combined with urogonadotrophin to promote ovulation after clomiphene treatment is ineffective.

        4. Used for in vitro fertilization to obtain multiple oocytes, in combination with menotrophin.

        5. Treatment of luteal insufficiency in women.

        6. Functional uterine bleeding, threatened miscarriage in the first trimester, recurrent miscarriage.

        Product Detail

        Product Tags


        Chorionic Gonadotrophin for injection


        Pregnant woman?urine


        This product is a freeze-dried sterile product with chorionic gonadotrophin plus suitable excipients. Its titer should be 80%~125% of the labeled amount Chorionic Gonadotrophin for Injection is a sterile material consisting of Chorionic Gonadotrophin with or without excipients. It is supplied in a sealedcontainer

        Pharmacopoeia standard




        This product is a white lyophilized block or powder. A white or almost white, amorphous powder


        _______ Causes an increase in the weight of the seminal vesicles or the prostate glands of immature male rats when administered as directed under the Assay.


        Loss on drying ≤5.0% _______
        Abnormal toxicity Conform with regulation
        Bacterial endotoxin ≤0.01EU/IU The endotoxin limit concentration of solution A is 15 IU of endotoxin per mL
        Acidity or alkalinity _______ pH of a 1% w/v solution, 6.0 to 8.0
        Clarity and colour of solution _______ Solution is clear?and colourless
        Content uniformity ±15% _______
        Visible foreign matter Conform with regulation _______
        Sterile Conform with regulation _______


        80%~125%?of the stated potency 80%~125%?of the stated potency


        Sealed and kept in a cool dark place. The sealed container should be protected from light and stored at a temperature not exceeding 20℃.


        Gonadotropin drugs


        1000 units ?????5000units

        1000 units? ?5000units


        Patients suspected of having pituitary hyperplasia or swelling and pain, prostate cancer or other androgen-related swelling and pain tumors are contraindicated (with promoting effect). Patients with precocious puberty, vaginal bleeding with an undiagnosed diagnosis, subordinate fibroids, ovarian cysts or ovarian enlargement, thrombophlebitis, and patients with a history of allergy to gonadal stimulating hormones are contraindicated.


        1. It should be used with caution in the following conditions: enlarged prostate, asthma, epilepsy, heart disease, migraine, renal impairment, etc.
        2. If ovarian hyperstimulation syndrome and ovarian enlargement, pleural effusion, ascites and other comorbidities are found, the drug should be discontinued or seek medical advice.
        3. The possibility of multiple pregnancies should be communicated to the patient before use. Ask about adverse reactions during use and conduct relevant clinical examinations regularly.
        4. Pregnancy tests can be falsely positive and should be tested 10 days after administration.
        5. Use with caution in patients with hypertension.
        6. This product is temporarily formulated before application.

      2. Previous:
      3. Next:

      4. Write your message here and send it to us

        Products categories